Question 1

Who are the top researchers at Noxxon Pharma (Germany)?

Accepted Answer

Ranked on the quality score, Dirk Eulberg, Sven Klußmann and Dirk Zboralski lead among researchers whose main affiliation is Noxxon Pharma (Germany).

Question 2

What are the most cited papers from Noxxon Pharma (Germany)?

Accepted Answer

The most cited paper from Noxxon Pharma (Germany) is "Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury" (Christer Baeck, Alexander Wehr, Karlin Raja Karlmark et al., 2011), with 618 citations. Next come "Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension" (413) and "Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury" (327).

Question 3

Which research topics does Noxxon Pharma (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Graphene and Nanomaterials Applications, Graphene research and applications, Frailty in Older Adults and Childhood Cancer Survivors' Quality of Life.

Question 4

Which keywords describe research at Noxxon Pharma (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Therapeutic Targets, Nanoparticles, Biosensors, Self-Assembly, aptamers, DNA nanotechnology, Nucleic Acids and DNA Structure.

Question 5

Which fields of science does Noxxon Pharma (Germany) work in?

Accepted Answer

In all years, 58% of research at Noxxon Pharma (Germany) is in Life Sciences, 33% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (47%), Medicine (32%), Immunology and Microbiology (7%). It does 3.3× the world's share of Life Sciences.

Question 6

Is Noxxon Pharma (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 91% lower than in 2018-2021.